| Literature DB >> 20811648 |
Else Vengnes Grue1, Harriet Finne-Soveri, Paul Stolee, Jeff Poss, Liv Wergeland Sörbye, Anja Noro, John P Hirdes, Anette Hylen Ranhoff.
Abstract
Information about recent visual decline (RVD) and its consequences is limited. The aim was to investigate this in an observational, prospective study. Participants were recipients of community home services, >/=65 years, from Ontario (Canada, n = 101618), Finland (the-RAI-database, STAKES, n = 1103), and 10 other European countries (the-Aged-in-HOmeCarestudy (AdHOC), n = 3793). The instrument RAI-HC version 2.0 was used in all sites. RVD was assessed by the item "Worsening of vision compared to status 90 days ago" and was present in 6-49% in various sites, more common among persons living alone, and in females. In the AdHOC sample, RVD was independently associated with declining social activity and limited outdoors activities due to fear of falling. The combination of stable vision impairment (SVI) and RVD was independently associated with IADL loss. RVD is common and has greater impact than SVI on social life and function. Caregivers should be particularly aware of RVD, its consequences, and help patients to seek assessments, treatment, and rehabilitation.Entities:
Year: 2010 PMID: 20811648 PMCID: PMC2929488 DOI: 10.1155/2010/503817
Source DB: PubMed Journal: Curr Gerontol Geriatr Res ISSN: 1687-7063
Comparison of the three databases.
| Database | |||
|---|---|---|---|
| Ontario RAI-HC data base, University of Waterloo, Canada | RAI-database STAKES, Finland | AdHOC study, Universita Cattolica de Sacro Cuore, Italy | |
|
| |||
| Countries included | Canada | Finland | Czech Republic, Denmark, Finland, France, Germany, Iceland, Italy, The Netherlands, Norway, Sweden, United Kingdom |
|
| |||
| Specific locations within countries | Ontario | Five home care agencies serving urban area in different parts of Finland | One or several home care agencies serving a urban area, in each of the countries |
|
| |||
| Criteria for selecting the homecare agencies | All in the province | Volunteer agencies | Volunteer agencies |
|
| |||
| Inclusion criteria for the homecare clients | Every client assessed once over a given time frame | Every client assessed once over a given time frame | Random sample assessed once over a given time frame |
|
| |||
| Refusal rates | None | None | 0–57% |
|
| |||
| Purpose for collecting data | Care planning, quality monitoring, and administrative decision making for homecare | On-going national initiative to improve statistics and quality of care within the elderly care services | Research study with a coaim to construct a European data base for home care |
|
| |||
| Collection of data | January 2004–December 2004 | July 2004–December 2004 | August 2001–December 2002 |
|
| |||
| Number extracted for the current analysis | 101.618 | 1.103 | 3.793 |
|
| |||
| Education of the data collectors | Standardised programs, ≥8 hours | Standardised national programs, ≥8 hours | Standardised programs, ≥8 hours |
|
| |||
| Funding | Ontario Ministry of Health and Long-Term Care | Local authorities and STAKES | European Union (5th framework) |
Figure 1Vision (based on self- and proxy reports and assessed by a simple reading test) in older people receiving homecare in 12 different country sites (%); N = 106328.
Figure 2Self-reported visual impairment, stable and changed, through last 90 days in older people receiving homecare in 12 different country sites (%). N = 106328.
Figure 3Visual ability in two groups of older homecare clients: stable visual impairment and recent visual decline (for the period of the last 90 days) (%); N = 3793.
Characteristics of patients in the AdHOC study in relation to self-reported vision; adequate vision (AV), stable visual impairment (S V I), and recent visual decline (R V D) (percentage of cases unless otherwise stated). P values indicate differences between the groups.
| All | AV | SVI | RVD |
|
|
| OR/SE diff. | |
|---|---|---|---|---|---|---|---|---|
| AV vs. SV | AV vs. RVD | SVI vs. RVD | (95% CI) | |||||
| Overall number (%) | 3793(100) | 2205(58.1) | 907(23.9) | 681(18.0) | ||||
| Demographic variables age (year) | ||||||||
| Mean (SD) min.-max. 65.1–104.5 | 82.3 (7.3) | 81.5 (7.3) | 83.5 (7.5) | 83.2 (7.2) | <.0001 | <.0001 | .390 | 0.37 (0.4–0.7) |
| <75 | 17.4 | 66.5 | 19.4 | 14.1 | <.0001 | <.0001 | .795 | 1.0 (0.7–1.3) |
| 75–84 | 43.8 | 60.3 | 22.2 | 17.5 | .014 | .221 | .388 | 1.1 (0.9–1.3) |
| ≥85 | 38.9 | 52.0 | 27.9 | 20.1 | <.0001 | <.0001 | .500 | 0.9 (0.8–1.1) |
| Female gender | 74.2 | 57.5 | 23.4 | 19.1 | .699 | .04 | .005 | 1.4 (1.1–1.8) |
| Lives alone | 61.6 | 60.2 | 20.5 | 19.3 | <.0001 | .259 | <.0001 | 1.8 (1.4–2.2) |
| Physical functioning | ||||||||
| Hearing impairment | 37.1 | 43.9 | 32.3 | 23.8 | <.0001 | <.0001 | .701 | 1.0 (0.8–1.2) |
| ADLc loss Hierarchy Scale (0–6) | ||||||||
| Mean (SD) min.-max. (0–4) | 0.6 (1.2) | 0.5 (1.0) | 1.1 (1.4) | 0.4 (1.0) | <.0001 | .088 | <.0001 | 0.06 (0.6–0.8) |
| ADL Hierarchy Scale (score >0) | 27.2 | 46.8 | 39.7 | 13.6 | <.0001 | <.0001 | <.0001 | 0.5 (0.4–0.6) |
| IADLd loss Involvement Scale (0–21) | ||||||||
| Mean (SD) min.-max. (0–21) | 5.1 (2.9) | 4.5 (2.7) | 6.3 (3.0) | 5.5 (3.0) | <.0001 | <.0001 | <.0001 | 0.15 (0.5–1.1) |
| IADL Involvement Scale (score ≥5) | 58.3 | 49.8 | 30.5 | 19.6 | <.0001 | <.0001 | <.0001 | 0.6 (0.5–0.7) |
| Mental functioning | ||||||||
| Cognitive Performance Scale CPS (0–6) | ||||||||
| Mean (SD) min.-max. (0–5) | 1.0 (1.4) | 0.8 (1.3) | 1.6 (1.7) | 1.0 (1.4) | <.0001 | <.0001 | <.0001 | 0.08 (0.4–0.7) |
| Cognitive impairment CPS scale ≥1 | 45.8 | 49.4 | 31.0 | 19.6 | <.0001 | <.0001 | <.0001 | 0.7 (0.6–0.8) |
| Change in cognition within 90 dd | 6.4 | 43.4 | 38.1 | 18.4 | <.0001 | <.0001 | .011 | 0.6 (0.4–0.9) |
| Depression Scale, DRS Scale (0–14) | ||||||||
| Mean (SD) min.-max. (0–14) | 1.1 (2.0) | 0.9 (1.8) | 1.3 (2.1) | 1.5 (2.4) | <.0001 | <.0001 | .014 | 0.11 (0.5–0.1) |
| Depression symptoms (DRS scale ≥3) | 16.1 | 46.5 | 27.3 | 26.2 | <.0001 | <.0001 | .013 | 1.4 (1.1–1.7) |
| Mood decline within 90 dd | 11.5 | 47.5 | 25.3 | 27.2 | .019 | <.0001 | .003 | 1.5 (1.1–2.0) |
| Social functioning | ||||||||
| Withdrawal from activities | 14.4 | 46.7 | 24.6 | 28.6 | .012 | <.0001 | <.0001 | 1.7 (1.3–2.2) |
| Reduced social interactions | 20.6 | 50.7 | 25.7 | 23.6 | .007 | <.0001 | .021 | 1.3 (1.0–1.6) |
| Social activity, changed | 34.7 | 53.0 | 20.6 | 26.3 | .349 | <.0001 | <.0001 | 2.4 (2.0–3.0) |
| Feelings of loneliness | 21.3 | 52.0 | 20.2 | 27.8 | .484 | <.0001 | <.0001 | 2.3 (1.8–2.8) |
| Conditions | ||||||||
| Dizziness | 23.5 | 53.6 | 18.6 | 27.8 | .035 | <.0001 | <.0001 | 2.6 (2.0–3.2) |
| Unsteady gait | 62.2 | 54.1 | 25.3 | 20.6 | <.0001 | <.0001 | .025 | 1.3 (1.0–1.6) |
| Limits on going outdoors | 47.6 | 50.8 | 26.4 | 22.8 | <.0001 | <.0001 | .002 | 1.4 (1.1–1.7) |
| Falls Mean (SD) min.-max. (0–12) | 0.6 (1.4) | 0.5 (1.3) | 0.7 (1.6) | 0.7 (1.5) | .010 | <.0001 | .410 | 0.08 (−0.2–0.1) |
| Any falls within 90 dd | 25.7 | 50.5 | 26.3 | 23.3 | <.0001 | <.0001 | .029 | 1.3 (1.0–1.6) |
| Experienced health | ||||||||
| Poor experienced health | 30.5 | 51.0 | 23.8 | 25.2 | .044 | <.0001 | <.0001 | 1.7 (1.4–2.1) |
| Medications | ||||||||
| Mean (SD) min.-max. (0–20) | 5.4 (2.9) | 5.3 (2.9) | 5.3 (2.9) | 6.1 (2.6) | .614 | <.0001 | <.0001 | 0.14 (1.2–0.6) |
| Polypharmacy (≥5 daily) | 62.4 | 55.9 | 23.3 | 20.8 | .715 | <.0001 | <.0001 | 1.7 (1.4–2.1) |
| Use of services | ||||||||
| Informal caregiver | 70.3 | 54.7 | 26.2 | 19.2 | <.0001 | <.0001 | .374 | 0.9 (0.7–1.1) |
| Any personal services | 68.9 | 56.3 | 25.4 | 18.3 | <.0001 | .077 | .190 | 0.9 (0.7–1.1) |
| Homemaking help | 47.3 | 60.5 | 20.3 | 19.2 | <.0001 | .565 | <.0001 | 1.5 (1.2–1.9) |
| Occupational therapy | 2.4 | 57.1 | 23.1 | 19.8 | .943 | .673 | .676 | 1.1 (0.6–2.2) |
| Emergency services at home | 5.5 | 49.5 | 23.6 | 26.9 | .390 | <.0001 | .025 | 1.6 (1.1–2.3) |
| Hospital episodes, over nights | 13.6 | 50.7 | 29.7 | 19.6 | <.0001 | .039 | .273 | 0.9 (0.7–1.1) |
| Hospital episodes, days | 5.0 | 51.6 | 20.0 | 28.4 | .752 | <.0001 | .002 | 2.0 (1.3–3.0) |
| Increase in care needs within 90 dd | 6.3 | 55.9 | 25.2 | 18.9 | .540 | .585 | 1.0 | 1.0 (0.7–1.5) |
| Cataract | 20.0 | 45.8 | 19.0 | 35.2 | .923 | <.0001 | <.0001 | 3.4 (2.7–4.3) |
| Glaucoma | 7.7 | 49.7 | 19.9 | 30.5 | .852 | <.0001 | <.0001 | 2.2 (1.6–3.1) |
aSVI = impaired vision not changed through the last 90 days, bRVD = vision declined through the last 90 days, cADL = activities of daily living, and dIADL = Instrumental activities of daily living.